Table of Contents Table of Contents
Previous Page  206 / 220 Next Page
Information
Show Menu
Previous Page 206 / 220 Next Page
Page Background

Likewise, other prior research has reported conflict-

ing results. A European case-control study of 1,774

HNSCC cases found no association between heartburn

and specific HNSCC tumor sites, except for an inverse

association with hypopharyngeal cancer (OR

5

0.64;

95% CI 0.44, 0.93).

13

Another epidemiologic study (1,303

cases) reported that ever-smoker/ever-drinker HNSCC

subjects were not more likely to have had a history of

GERD than never-smoker/never-drinker HNSCC

patients.

14

A small case-control study (120 cases) exam-

ined associations between

H. pylori

infection, a cause of

GERD, and odds of laryngopharyngeal cancer but found

no association (OR

5

1.53; 95% CI 0.69, 3.41).

15

Studies of the etiologic role of GERD in laryngeal

cancer have arrived at different conclusions. A meta-

analysis concluded that GERD was associated with an

increased odds of laryngeal cancer (OR

5

2.21; 95% CI

1.53, 3.19) but not pharyngeal cancer, although the

pharynx OR was extremely imprecise.

16

A literature

review that was not a meta-analysis could not conclude

that GERD caused laryngeal cancer, but noted that con-

founding by alcohol and tobacco consumption were inad-

equately controlled.

17

A large case-control study

conducted in the Veterans Health Administration system

(14,449 cases) found no association between GERD and

laryngeal cancer (OR

5

1.01; 95% CI 0.92, 1.12).

18

An important strength of our study was examina-

tion of two different measures of GERD exposure: 1)

self-reported history of symptoms and medical diagnosis

and 2) development of HNSCC. A medical diagnosis of

GERD is more likely to indicate substantial GERD mor-

bidity than a self-reported history of having had fre-

quent heartburn, resulting in less misclassification.

Second, our analysis was based on a large, population-

based case-control study, making it representative of a

well-defined source population and increasing the preci-

sion of the effect estimates. Third, CHANCE has

detailed information on alcohol and tobacco consump-

tion, important causes of HNSCC not well measured in

a number of previous studies that examined relation-

ships between GERD and HNSCC.

17

This enabled us to

appropriately control for the effects of tobacco and

alcohol.

In terms of limitations, our assessment of GERD by

self-report was not as accurate as an objective measure-

ment such as pH monitoring would be,

5

even when the

self-reported measure was medical diagnosis of GERD

rather than self-assessment of GERD symptoms. Medi-

cal diagnosis of GERD was ascertained by asking sub-

jects whether they were ever diagnosed with GERD by a

doctor rather than abstracting the information from

medical records. Furthermore, even among self-reported

measures of GERD, our simple one-question assessment

might not be as accurate or reliable as validated multi-

question instruments such as the Reflux Symptom

Index.

19

However, alternative measures of self-reported

GERD were not available in CHANCE. There is the pos-

sibility of misclassification of the history of GERD, espe-

cially if subjects are not aware of the criteria for

frequency and severity of symptoms used to diagnose

GERD.

20

For example, subjects who are not aware of

frequency criteria and assume that their symptoms do

not occur frequently enough to warrant being considered

a medical diagnosis could falsely report not having had

GERD exposure, thereby possibly attenuating estimates

of an association between GERD and HNSCC.

Future research on GERD and HNSCC must con-

sider the differing study designs and inconsistent find-

ings of results reported to date. A larger study may be

beneficial to further elucidate this association. Such a

study would need to provide adequate control for tobacco

and alcohol consumption as well as obesity, as was done

here.

5

It would be informative to compare the effect of

GERD when measured by self-report, medical diagnosis

as ascertained by medical records, and by pH monitoring

or another objective measurement. Multiple measures of

self-reported GERD could be used for purposes of com-

parison, including questionnaires such as the Reflux

Symptom Index.

19

Because a few of our site-specific

associations suggested greater risk, estimates of the

association of GERD with HNSCC should be conducted

for both overall HNSCC as well as individual tumor

sites, as was done here.

CONCLUSION

In summary, we find no general pattern of associa-

tion between GERD and the development of HNSCC.

Subgroup analysis of subjects who were neither heavy

drinkers nor heavy smokers does not show an associa-

tion between GERD and the development of laryngo-

pharyngeal cancer, a finding that conflicts with prior

research. However, whereas none of our associations is

statistically significant, the patterns of some point esti-

mates, such as the larynx result, are suggestive and

should be further investigated in future larger studies.

Such additional work would help to resolve the inconsis-

tencies observed in this literature.

BIBLIOGRAPHY

1. Spechler SJ. Clinical manifestations and esophageal complications of

GERD.

Am J Med Sci

2003;326:279–284.

2. Williams JL. Gastroesophageal reflux disease: clinical manifestations.

Gas-

troenterol Nurs

2003;26:195–200.

3. Kapoor H, Agrawal DK, Mittal SK. Barrett’s esophagus: recent insights

into pathogenesis and cellular ontogeny.

Transl Res

2015;166:28–40. doi:

10.1016/j.trsl.2015.01.009

.

4. Wang RH. From reflux esophagitis to Barrett’s esophagus and esophageal

adenocarcinoma.

World J Gastroenterol

2015;21:5210–5219.

5. Herbella FA, Neto SP, Santoro IL, Figueiredo LC. Gastroesophageal reflux

disease and nonesophageal cancer.

World J Gastroenterol

2015;21:815–

819.

6. Langevin SM, Michaud DS, Marsit CJ, et al. Gastric reflux is an inde-

pendent risk factor for laryngopharyngeal carcinoma.

Cancer Epidemiol

Biomarkers Prev

2013;22:1061–1068.

7. Johnston N, Dettmar PW, Strugala V, Allen JE, Chan WW. Laryngophar-

yngeal reflux and GERD.

Ann N Y Acad Sci

2013;1300:71–79.

8. Kuo CL, Chen YT, Shiao AS, Lien CF, Wang SJ. Acid reflux and head and

neck cancer risk: A nationwide registry over 13 years.

Auris Nasus Lar-

ynx

2015;42:401–405. doi:

10.1016/j.anl.2015.03.008.

9. Johnston N, Yan JC, Hoekzema CR, et al. Pepsin promotes proliferation of

laryngeal and pharyngeal epithelial cells.

Laryngoscope

2012;122:1317–

1325.

10. Kelly EA, Samuels TL, Johnston N. Chronic pepsin exposure pro-

motes anchorage-independent growth and migration of a hypophar-

yngeal squamous cell line.

Otolaryngol Head Neck Surg

2014;150:

618–624.

11. Divaris K, Olshan AF, Smith J, et al. Oral health and risk for head and

neck squamous cell carcinoma: the Carolina Head and Neck Cancer

Study.

Cancer Causes Control

2010;21:567–575.

12. Stingone JA, Funkhouser WK, Weissler MC, Bell ME, Olshan AF. Racial

differences in the relationship between tobacco, alcohol, and squamous

Laryngoscope 126: May 2016

Busch et al.: GERD and Head and Neck Cancer

186